ALLO - Latest News
Allogene Therapeutics, Inc. (ALLO), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $568.2M. Beta to the broader market is 0.46.
The article list below shows the most recent ALLO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ALLO Headlines
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1
zacks.com - May 14, 2026
ALLO posts a narrower Q1 loss, raises its 2026 expense outlook and shares positive interim data from its pivotal ALPHA3 study.
Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
247wallst.com - May 14, 2026
Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for growth.
Allogene Therapeutics, Inc. (ALLO) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 14, 2026
Allogene Therapeutics, Inc.
Allogene Therapeutics Q1 Earnings Call Highlights
marketbeat.com - May 13, 2026
Allogene Therapeutics NASDAQ: ALLO said its first quarter of 2026 was marked by early clinical progress for its lead allogeneic CAR-T programs and a s
Allogene Therapeutics ends China cell therapy deal with Overland
reuters.com - May 13, 2026
Allogene Therapeutics said on Wednesday it has ended a key partnership for developing cell therapies in parts of Asia and reworked its equity stake
How News Affects ALLO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ALLO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ALLO news questions
- What is the latest ALLO news headline?
- The most recent ALLO headline (May 14, 2026) is "Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ALLO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ALLO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ALLO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.